Bio-Rad Expands ddPCR Offering Through Strategic Acquisition and Platform Rollout
Bio-Rad Laboratories has expanded its ddPCR product portfolio with four new platforms, including the QX Continuum and QX700 series.
Category: Molecular Diagnostic Analyzers
Molecular Diagnostic Analyzers
Latest
Molecular Diagnostic Analyzers
Latest
FDA Clears Cardiac Troponin I Test for Myocardial Infarction Diagnosis
The new high-sensitivity troponin assay is designed for use on the the PATHFAST Biomarker Analyzer from Polymedco.
Molecular Diagnostic Analyzers
Latest
De Novo Submission Made for Full Clearance of its Cue RSV Molecular Test
Cue Health announced that it has made a De Novo submission to the FDA for full clearance of the Cue RSV Molecular Test.
COVID-19 Pandemic Pivot Shows the Benefits of Microarray Technology
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read More
DNA Testing Could Unlock Cancer’s Ancestral Roots
Researchers are revealing connections between cancer and race or ethnicity with software that infers ancestral roots in tumor DNA and RNA.
Read More
Bacterial Vaginosis & Trichomoniasis: Test-and-Treat as a Critical Component in Diagnosis
Bacterial vaginosis and trichomoniasis results in a range of health complications. A test-and-treat approach can improve diagnosis.
Read More
Llusern Debuts UTI Molecular Diagnostic Platform
UK diagnostics manufacturer, Llusern Scientific, will preview its Lodestar DX molecular diagnostic platform at the upcoming Medica 2022.
Read More
Exome Sequencing May Have Utility for Diagnosing Autism
Research underscores the positive outcomes of exome sequencing for individuals with ASD, supporting its use to reach a faster diagnosis.
Read More
Genetic Testing Helps Spot Children Likely to Have Heart Failure
Genetic testing can diagnose cardiomyopathy in children and help detect who will have heart failure and require a transplant.
Read More
Cue Applies for EUA for Flu + COVID-19 Molecular Test
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read More
Cost-Effective Approach to Early Detection of Cancer Tested
UCLA researchers have found a cost-effective way for early detection of cancer using cell-free DNA in blood samples.
Read More
Who Should Be the Industry Watchmen?
Theranos whistleblower Tyler Shultz sees what he did as an in-case-of-emergency break glass option. But who should be the industry watchmen?
Read More
BD Launches Fully Automated, High-Throughput Disease Molecular Diagnostic Platform
BD announced the U.S. launch of its new, fully automated, high-throughput infectious disease molecular diagnostics platform.
Read More
Thermo Fisher Scientific Real-Time PCR System Adds 384-Well Option
A 384-well option is now available for Thermo Fisher Scientific’s Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System.
Read More
Hologic Launches High Volume Molecular Testing Platform
Panther Trax’s broad assay menu includes tests for women’s health, sexually transmitted infections (STIs), respiratory health, COVID-19 testing, and more.
Read More
BD Expands Diagnostic Platform to Include Infectious Disease Testing
BD has expanded its BD COR System to include a new MX instrument for high-throughput molecular testing for infectious diseases.
Read More
Applied BioCode Launches 28 Fungal Analyte-Specific Reagents
Applied BioCode has released 28 Fungal Analyte-Specific Reagents for use in molecular tests, which utilize the company’s BMB technology.
Read More
simplSEQ Demonstrates Value of New DNA and RNA Isolation Technology
simplSEQ, Inc. presented a poster showing the value of its technology in isolating DNA and RNA from whole blood at the 2021 AMP annual meeting.
Read More